| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |